2-147900020-A-G
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_001616.5(ACVR2A):c.528+122A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.591 in 1,135,974 control chromosomes in the GnomAD database, including 204,465 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.50 ( 20916 hom., cov: 32)
Exomes 𝑓: 0.61 ( 183549 hom. )
Consequence
ACVR2A
NM_001616.5 intron
NM_001616.5 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 1.00
Publications
10 publications found
Genes affected
ACVR2A (HGNC:173): (activin A receptor type 2A) This gene encodes a receptor that mediates the functions of activins, which are members of the transforming growth factor-beta (TGF-beta) superfamily involved in diverse biological processes. The encoded protein is a transmembrane serine-threonine kinase receptor which mediates signaling by forming heterodimeric complexes with various combinations of type I and type II receptors and ligands in a cell-specific manner. The encoded type II receptor is primarily involved in ligand-binding and includes an extracellular ligand-binding domain, a transmembrane domain and a cytoplasmic serine-threonine kinase domain. This gene may be associated with susceptibility to preeclampsia, a pregnancy-related disease which can result in maternal and fetal morbidity and mortality. Alternative splicing results in multiple transcript variants of this gene. [provided by RefSeq, Jun 2013]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.65).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.641 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| ACVR2A | NM_001616.5 | c.528+122A>G | intron_variant | Intron 4 of 10 | ENST00000241416.12 | NP_001607.1 | ||
| ACVR2A | NM_001278579.2 | c.528+122A>G | intron_variant | Intron 5 of 11 | NP_001265508.1 | |||
| ACVR2A | NM_001278580.2 | c.204+122A>G | intron_variant | Intron 4 of 10 | NP_001265509.1 | |||
| ACVR2A | XM_047446292.1 | c.204+122A>G | intron_variant | Intron 4 of 10 | XP_047302248.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| ACVR2A | ENST00000241416.12 | c.528+122A>G | intron_variant | Intron 4 of 10 | 1 | NM_001616.5 | ENSP00000241416.7 |
Frequencies
GnomAD3 genomes AF: 0.499 AC: 75684AN: 151818Hom.: 20911 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
75684
AN:
151818
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.605 AC: 595359AN: 984038Hom.: 183549 AF XY: 0.607 AC XY: 299193AN XY: 492562 show subpopulations
GnomAD4 exome
AF:
AC:
595359
AN:
984038
Hom.:
AF XY:
AC XY:
299193
AN XY:
492562
show subpopulations
African (AFR)
AF:
AC:
4922
AN:
21544
American (AMR)
AF:
AC:
10805
AN:
21982
Ashkenazi Jewish (ASJ)
AF:
AC:
10350
AN:
17424
East Asian (EAS)
AF:
AC:
16686
AN:
33698
South Asian (SAS)
AF:
AC:
37359
AN:
57354
European-Finnish (FIN)
AF:
AC:
24745
AN:
40084
Middle Eastern (MID)
AF:
AC:
1961
AN:
4240
European-Non Finnish (NFE)
AF:
AC:
463141
AN:
744294
Other (OTH)
AF:
AC:
25390
AN:
43418
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.509
Heterozygous variant carriers
0
11031
22063
33094
44126
55157
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
11270
22540
33810
45080
56350
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.498 AC: 75712AN: 151936Hom.: 20916 Cov.: 32 AF XY: 0.504 AC XY: 37419AN XY: 74264 show subpopulations
GnomAD4 genome
AF:
AC:
75712
AN:
151936
Hom.:
Cov.:
32
AF XY:
AC XY:
37419
AN XY:
74264
show subpopulations
African (AFR)
AF:
AC:
10287
AN:
41482
American (AMR)
AF:
AC:
7820
AN:
15234
Ashkenazi Jewish (ASJ)
AF:
AC:
2107
AN:
3472
East Asian (EAS)
AF:
AC:
2502
AN:
5160
South Asian (SAS)
AF:
AC:
3181
AN:
4816
European-Finnish (FIN)
AF:
AC:
6631
AN:
10562
Middle Eastern (MID)
AF:
AC:
128
AN:
290
European-Non Finnish (NFE)
AF:
AC:
41445
AN:
67896
Other (OTH)
AF:
AC:
1027
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1768
3536
5304
7072
8840
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
678
1356
2034
2712
3390
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2077
AN:
3476
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.